Prestigious Award Recognizes Groundbreaking Immune System Discoveries

This year's Nobel Prize in medical science has been granted for transformative discoveries that illuminate how the body's defense network attacks dangerous infections while protecting the healthy tissues.

A trio of renowned scientists—from Japan Shimon Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this honor.

Their work identified unique "sentinels" within the immune system that eliminate rogue defense cells that could attacking the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These winners will divide a prize fund worth 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for understanding how the immune system functions and the reason we do not all develop serious self-attack conditions," commented the chair of the Nobel Committee.

This team's studies explain a fundamental question: How does the immune system defend us from countless infections while keeping our healthy cells intact?

Our immune system uses white blood cells that scan for signs of disease, even viruses and germs it has never encountered.

Such defenders utilize detectors—known as receptors—that are produced by chance in countless combinations.

This provides the defense network the ability to fight a broad range of invaders, but the randomness of the process inevitably creates immune cells that can target the host.

Protectors of the Immune System

Researchers earlier understood that a portion of these harmful white blood cells were eliminated in the thymus—the site where white blood cells mature.

The latest award honors the identification of T-reg cells—known as the immune system's "peacekeepers"—which patrol the body to disarm other defenders that attack the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee stated, "These discoveries have established a new field of research and accelerated the creation of innovative therapies, for instance for cancer and autoimmune diseases."

Regarding cancer, T-regs block the system from fighting the tumor, so studies are aimed at reducing their quantity.

For self-attack disorders, trials are exploring boosting T-reg cells so the organism is no longer under attack. A similar method could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Studies

Prof Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their immune gland extracted, leading to self-attack conditions.

He demonstrated that injecting defense cells from other mice could prevent the disease—suggesting there was a system for preventing immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an inherited immune disorder in mice and humans that led to the discovery of a genetic factor critical for the way regulatory T-cells function.

"The groundbreaking work has revealed how the immune system is kept in check by T-reg cells, preventing it from mistakenly targeting the body's own tissues," said a leading biological science specialist.

"This work is a striking example of how basic biological study can have broad implications for public health."